Open AccessProspective Risk-Adjusted [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography Assessment of Radiation Response in Head and Neck Cancer
Author(s) -
Benjamin J. Moeller,
Vishal Rana,
B Can,
Michelle D. Williams,
Erich M. Sturgis,
Lawrence E. Ginsberg,
Homer A. Macapinlac,
J. Jack Lee,
K. Kian Ang,
K. S. Clifford Chao,
Gregory M. Chronowski,
Steven J. Frank,
William H. Morrison,
David I. Rosenthal,
Randal S. Weber,
Adam S. Garden,
Scott M. Lippman,
David A. Schwartz
Publication year - 2009
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2008.19.3300
Subject(s) - medicine , positron emission tomography , nuclear medicine , head and neck cancer , computed tomography , positron emission , fluorodeoxyglucose , head and neck , radiology , tomography , radiation therapy , prospective cohort study , positron emission tomography computed tomography , surgery
[(18)F]Fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) imaging may improve assessment of radiation response in patients with head and neck cancer, but it is not yet known for which patients this is most useful. We conducted a prospective trial to identify patient populations likely to benefit from the addition of functional imaging to the assessment of radiotherapy response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom